Skip to main content
Australian employees cleaning up a park.)

Environment

Minimising our Environmental Impacts

Our commitment to a healthier world means delivering for both people and our planet. For a century we have strived to provide our life-saving medicines in an efficient, inclusive and environmentally respectful way. We take this responsibility seriously, and our promise is to continue to further build environmental considerations into our business so we can deliver a sustainable world for the next century and beyond.

In addition to material topics featured, our strategic sustainability focus areas include the following: 
  • Integrate sustainability considerations into business decisions.
  • Reduce carbon emissions.
  • Minimise end to end production of waste through removal, reduction and recycling.
  • Reduce carbon emissions/waste in our supply chain.

Environmental protection
At CSL, we recognise that responsible management and efficient use of natural resources is key to our sustainable growth and our ability to enable efficient and reliable supply of our life-saving medicines. 

CSL has an Environment, Health, Safety and Sustainability (EHS2) function, which ensures its facilities operate to industry and regulatory standards. This strategy includes compliance with government regulations and commitments to minimise the impact of operations on the environment. Our EHS2 Management System provides the platform for policies, procedures and guidelines, which manage our business processes. We are committing resources and time into new technology to capture, calculate and report global environmental data, a significant steppingstone to delivering on our roadmap for achieving our emissions reduction targets. 

In 2021/22, across our network of manufacturing facilities and CSL Plasma centres there were no breaches of environmental laws that resulted in a financial penalty or public notice.

Our target

As part of the environment pillar of our strategy, we set out to develop targets based on validated data sets and robust baselines. As a result of this effort, and in alignment with Science Based Targets, we commit to a 40% reduction in absolute Scope 1 and 2 emissions by 2030, using the average of CSL’s FY19-21 emissions as the basis. Further, we intend to ensure that suppliers who contribute 67% of our Scope 3 emissions have set Science-Based Targets initiative aligned Scope 1 and Scope 2 reductions by 2030.